Tesamorelin vs Sermorelin
Compare two related GH-axis options in a neutral clinical comparison guide.
Not for emergencies. Call 911 if experiencing medical emergency.
Body Composition
Learn how tesamorelin is discussed clinically, where evidence is strongest, and what monitoring matters before treatment decisions.
Tesamorelin is a stabilized GHRH analog. The active ingredient is FDA-approved as Egrifta SV for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy, and broader body-composition discussions should stay anchored to that narrower evidence context.
Compare two related GH-axis options in a neutral clinical comparison guide.
Tesamorelin has a modified structure providing stronger GH stimulation and clearer trial data in a narrower FDA-approved visceral-fat setting.
Adults 21+ who want to discuss clinician-guided body-composition or visceral-fat support may want to review tesamorelin with a clinician. Fit depends on medical history, goals, metabolic profile, and follow-up plan.
Review visceral-fat or body-composition goals, prior GHRH or GH-related therapy, current medications, recent labs if available, and any symptoms that may affect risk. Your clinician should discuss monitoring, expected time horizon, and what would prompt a hold or re-evaluation.
Severe or worsening symptoms, signs of allergic reaction, chest pain, trouble breathing, neurologic symptoms, or inability to keep fluids down should prompt urgent evaluation. Telehealth is not emergency care. Call 911 or go to the nearest emergency department for life-threatening symptoms.
No. Eligibility, tolerability, and outcomes vary by person. Prescriptions are never automatic or guaranteed, and treatment decisions are made by a licensed clinician based on your history, current medications, contraindications, and goals.
This page is educational content from the New Blue Health Clinical Content Team. It is reviewed under the New Blue Health Medical Review Policy and Editorial Policy and should not replace individualized medical advice from a licensed clinician. For how we evaluate evidence, see Evidence Methodology and Clinical Sources & References.